Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.43 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.43 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.43 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.43 |
| ▸ | KDM5C | P41229 | 3/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.41 |
| ▸ | KDM6B | O15054 | 2/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.35 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL362990 | 0.98 | LMNA (0.45) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| SCHEMBL10551554 | 0.95 | LMNA (0.43) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| SCHEMBL28805661 | 0.95 | LMNA (0.43) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| Water SCHEMBL16597988 | 0.95 | LMNA (0.43) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| SCHEMBL19993984 | 0.95 | LMNA (0.43) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| SCHEMBL9862683 | 0.95 | LMNA (0.43) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| Alcohol SCHEMBL8906908 | 0.89 | EGLN1 (0.42) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| SCHEMBL362989 | 0.87 | TSHR (0.38) | TSHR | |
| Ether SCHEMBL16597987 | 0.86 | EGLN1 (0.39) | LMNAEGLN1ALKBH5SUCNR1KDM5C | |
| Monoethanolamine SCHEMBL5703751 | 0.86 | LMNA (0.37) | LMNAEGLN1ALKBH5SUCNR1KDM5C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230120190-A1 | ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND INORGANIC COMPONENTS FOR FULL MAINTENANCE OF ORAL HEALTH, PROCESS FOR OBTAINING AND USES THEREOF | TEIXEIRA MARCELO RODRIGUES (BR) | 2023-04-20 | — | — | US | claimed |
| EP-4098242-A1 | ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND INORGANIC COMPONENTS FOR COMPLETE MAINTENANCE OF ORAL HEALTH, METHOD FOR OBTAINING SAME AND USES | Teixeira, Marcelo Rodrigues (BR) | 2022-12-07 | — | — | EP | claimed |
| US-20230120190-A1 | ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND INORGANIC COMPONENTS FOR FULL MAINTENANCE OF ORAL HEALTH, PROCESS FOR OBTAINING AND USES THEREOF | TEIXEIRA MARCELO RODRIGUES (BR) | 2023-04-20 | — | — | US | disclosed |
| EP-4098242-A1 | ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND INORGANIC COMPONENTS FOR COMPLETE MAINTENANCE OF ORAL HEALTH, METHOD FOR OBTAINING SAME AND USES | Teixeira, Marcelo Rodrigues (BR) | 2022-12-07 | — | — | EP | disclosed |
| EP-1703890-B1 | PEARLIZER CONCENTRATE AND ITS USE IN PERSONAL CARE COMPOSITIONS | RHODIA (US) | 2010-11-17 | — | — | EP | disclosed |
| US-7578995-B2 | Pearlizer concentrate and its use in personal care compositions | RHODIA INC. (US) | 2009-08-25 | — | — | US | disclosed |
| US-20080319090-A1 | Pearlizer concentrate and its use in personal care compositions | RHODIA INC. (US) | 2008-12-25 | — | — | US | disclosed |
| EP-1703890-A1 | PEARLIZER CONCENTRATE AND ITS USE IN PERSONAL CARE COMPOSITIONS | Rhodia Inc. (US) | 2006-09-27 | — | — | EP | disclosed |
| WO-2005070375-A1 | PEARLIZER CONCENTRATE AND ITS USE IN PERSONAL CARE COMPOSITIONS | RHODIA INC. (US) | 2005-08-04 | — | — | WO | disclosed |
| US-20050158270-A1 | Pearlizer concentrate and its use in personal care compositions | RHODIA INC. | 2005-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319090-A1 | Pearlizer concentrate and its use in personal care compositions | CUTA, PHOSPHO1, PEX14 | LMNA 682/4885EGLN1 3152/4885ALKBH5 3870/4885 |
| US-20050158270-A1 | Pearlizer concentrate and its use in personal care compositions | CUTA, PHOSPHO1, PEX14 | LMNA 682/4885EGLN1 3152/4885ALKBH5 3870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.